Cancer Pain
Investigational drug study evaluating the efficacy, safety and tolerability of study drug for cancer pain.
Eligible Participants: - 18 years old or older
- Participants who experience less than four episodes of breakthrough pain a day
- Participant’s pain associated with cancer treatment.
- Patients must currently be on a stable ongoing opioid therapy to control cancer-related pain
*study-related lab work, office visits and study drug available at no charge *compensation for time and travel is available
Contact PainPathways for more information on this research trial
at 336.714.8389
For more information about other current government research trials, visit www.clinicaltrials.gov
A service of the U.S. National Institutes of Health